Boston Scientific Announces $1.5 Billion Strategic Investment in MiRus LLC to Accelerate Innovation in Advanced Medical Technologies
Marlborough, MA — ANewswire — May 18, 2026 – Boston Scientific Corporation (NYSE: BSX) today announced it has invested $1.5 billion in return for an approximately 34% equity stake in MiRus LLC, a privately-held company developing and commercializing proprietary biomaterials,…


